Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Neurocrine Bioscienc (NBIX)

Neurocrine Bioscienc (NBIX)
90.75 x 1 100.76 x 1
Post-market by (Cboe BZX)
95.65 -7.23 (-7.03%) 04/04/25 [NASDAQ]
90.75 x 1 100.76 x 1
Post-market 96.42 +0.77 (+0.81%) 16:03 ET
Quote Overview for Fri, Apr 4th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
93.59
Day High
100.52
Open 99.40
Previous Close 102.88 102.88
Volume 2,452,044 2,452,044
Avg Vol 1,310,497 1,310,497
Stochastic %K 11.92% 11.92%
Weighted Alpha -38.30 -38.30
5-Day Change -17.51 (-15.47%) -17.51 (-15.47%)
52-Week Range 93.59 - 157.98 93.59 - 157.98
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,257,548
  • Shares Outstanding, K 99,704
  • Annual Sales, $ 2,355 M
  • Annual Income, $ 341,300 K
  • EBIT $ 571 M
  • EBITDA $ 571 M
  • 60-Month Beta 0.33
  • Price/Sales 4.58
  • Price/Cash Flow 32.05
  • Price/Book 4.23

Options Overview Details

View History
  • Implied Volatility 50.90% ( +3.39%)
  • Historical Volatility 35.14%
  • IV Percentile 88%
  • IV Rank 39.51%
  • IV High 94.83% on 08/06/24
  • IV Low 22.21% on 05/16/24
  • Put/Call Vol Ratio 0.26
  • Today's Volume 423
  • Volume Avg (30-Day) 562
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 15,178
  • Open Int (30-Day) 16,558

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.63
  • Number of Estimates 10
  • High Estimate 1.33
  • Low Estimate -0.30
  • Prior Year 0.42
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.59 +2.20%
on 04/04/25
Period Open: 113.11
116.23 -17.71%
on 03/26/25
-17.46 (-15.44%)
since 03/04/25
3-Month
93.59 +2.20%
on 04/04/25
Period Open: 138.10
154.61 -38.13%
on 01/30/25
-42.45 (-30.74%)
since 01/03/25
52-Week
93.59 +2.20%
on 04/04/25
Period Open: 137.61
157.98 -39.45%
on 08/01/24
-41.96 (-30.49%)
since 04/04/24

Most Recent Stories

More News
Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential

Explore the exciting world of Neurocrine Biosciences (NASDAQ: NBIX) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends...

NVDA : 94.31 (-7.36%)
NBIX : 95.65 (-7.03%)
Why Neurocrine Biosciences Stock Sank Today

Despite better-than-expected profitability in the fourth quarter, which it reported late last week, Neurocrine Biosciences (NASDAQ: NBIX) hasn't been wowing analysts lately. On Monday, no less than three...

NBIX : 95.65 (-7.03%)
UBS : 26.76 (-5.17%)
Neurocrine Biosciences Reports Mixed Q4

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while revenue slightly missed estimates.

NBIX : 95.65 (-7.03%)
TEVA : 13.80 (-7.07%)
Neurocrine: Q4 Earnings Snapshot

Neurocrine: Q4 Earnings Snapshot

NBIX : 95.65 (-7.03%)
Neurocrine: Q3 Earnings Snapshot

Neurocrine: Q3 Earnings Snapshot

NBIX : 95.65 (-7.03%)
Implied Volatility Surging for Neurocrine Biosciences (NBIX) Stock Options

Investors in Neurocrine Biosciences, Inc. NBIX need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 15, 2024 $80.00 Call had some of the highest...

NBIX : 95.65 (-7.03%)
"Rule Breaker Investing" Market Cap Game Show: Throwdowns & Long-Term Wins

Motley Fool analysts Matt Argersinger and Yasser El-Shimy face off.

MSFT : 359.84 (-3.56%)
SHOP : 76.89 (-6.56%)
LOW : 223.29 (+0.35%)
TDG : 1,237.85 (-9.21%)
NBIX : 95.65 (-7.03%)
AMD : 85.76 (-8.57%)
RKLB : 16.37 (-8.50%)
SONO : 8.60 (-3.43%)
HEI : 241.72 (-6.74%)
SYNA : 48.25 (-7.28%)
KFRC : 46.75 (-1.04%)
3 Top Growth Stocks to Buy at a Discount This Month

According to analysts, here are three top-notch mid-cap growth stocks to snag at a discount now.

$IDX : 2,648.54 (-4.83%)
NBIX : 95.65 (-7.03%)
FLR : 31.02 (-8.68%)
$SPX : 5,074.08 (-5.97%)
SON : 43.78 (-4.76%)
Why Neurocrine Biosciences Stock Was Tumbling This Week

The company promises to advance a top investigational drug to late-stage testing, but investors might not think that's a fine idea.

NBIX : 95.65 (-7.03%)
New Study Reveals How Classical Music Could Revolutionize Depression Care

In a groundbreaking study, Chinese scientists have revealed that classical music could be a powerful tool in the fight against treatment-resistant depression, a condition that affects nearly 50% of patients...

ALZN : 0.9827 (-3.66%)
NBIX : 95.65 (-7.03%)
TAK : 14.72 (-3.09%)
AXSM : 98.86 (-8.37%)
BIIB : 122.98 (-5.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding...

See More

Key Turning Points

3rd Resistance Point 106.51
2nd Resistance Point 103.52
1st Resistance Point 99.58
Last Price 95.65
1st Support Level 92.65
2nd Support Level 89.66
3rd Support Level 85.72

See More

52-Week High 157.98
Fibonacci 61.8% 133.38
Fibonacci 50% 125.78
Fibonacci 38.2% 118.19
Last Price 95.65
52-Week Low 93.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades